Envista Holdings (NVST)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-05
$24.96-8.20%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-11-05
QuarterlyIQ Insights · NVST
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -19.7% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the opposite direction.
Price observations: 365 days
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the US dollar and the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 3.1% |
Growth built into the price is above our model estimate.
The price assumes 22.8 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 14 industry peers · Company calendar date is not available
NVST — Principal Accounting Officer transition
Dated 2026-06-03
Chief Accounting Officer — Faez Kaabi: Mr. Kaabi is retiring and will be succeeded by Coree Thomas.
Why it matters: The system added to margin growth in Q2. Another gain would show that its savings work continues.
Supportive ifQ3 adjusted EBITDA margin is above 14.7%. Envista cites more gains from its business system.
Worry ifQ3 adjusted EBITDA margin is 14.7% or lower, with no further gains from the business system.
Why it matters: Envista raised its 2026 sales growth outlook after a strong first half. Q3 growth can show if that pace continues.
Supportive ifIn the Nov. 4 results, Q3 core sales growth is above 3.5% year over year, and Envista keeps its 3.5% to 4.5% full-year outlook.
Worry ifQ3 core sales growth is below 3.5%, or Envista cuts its 3.5% to 4.5% full-year outlook.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$123 on $10,000 · ±1.2% | How much price usually moves either way. |
| Bad day | $335 loss on $10,000 · 3.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,597 loss on $10,000 · 26.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.